Rank | Gene Set | Z-score |
---|---|---|
1 | cell migration involved in heart development (GO:0060973) | 4.49130248 |
2 | protein heterotrimerization (GO:0070208) | 4.37035115 |
3 | regulation of short-term neuronal synaptic plasticity (GO:0048172) | 4.30662949 |
4 | vocalization behavior (GO:0071625) | 4.28657868 |
5 | synaptic vesicle maturation (GO:0016188) | 4.00574362 |
6 | positive regulation of calcium ion-dependent exocytosis (GO:0045956) | 3.98830993 |
7 | cell communication by electrical coupling involved in cardiac conduction (GO:0086064) | 3.88931954 |
8 | synaptic vesicle exocytosis (GO:0016079) | 3.85798455 |
9 | regulation of cardiac muscle contraction by regulation of the release of sequestered calcium ion (GO | 3.72786445 |
10 | regulation of synapse structural plasticity (GO:0051823) | 3.71325636 |
11 | positive regulation of ryanodine-sensitive calcium-release channel activity (GO:0060316) | 3.68523744 |
12 | membrane depolarization during cardiac muscle cell action potential (GO:0086012) | 3.67810504 |
13 | locomotory exploration behavior (GO:0035641) | 3.67782180 |
14 | low-density lipoprotein particle clearance (GO:0034383) | 3.67472634 |
15 | basement membrane organization (GO:0071711) | 3.63816799 |
16 | regulation of cardiac muscle contraction by calcium ion signaling (GO:0010882) | 3.61598133 |
17 | virion attachment to host cell (GO:0019062) | 3.52310119 |
18 | adhesion of symbiont to host cell (GO:0044650) | 3.52310119 |
19 | cell communication by electrical coupling (GO:0010644) | 3.51722230 |
20 | barbed-end actin filament capping (GO:0051016) | 3.48781239 |
21 | regulation of alpha-amino-3-hydroxy-5-methyl-4-isoxazole propionate selective glutamate receptor act | 3.48025716 |
22 | positive regulation of potassium ion transmembrane transporter activity (GO:1901018) | 3.42201631 |
23 | extracellular fibril organization (GO:0043206) | 3.42194800 |
24 | regulation of release of sequestered calcium ion into cytosol by sarcoplasmic reticulum (GO:0010880) | 3.40337932 |
25 | neurotransmitter secretion (GO:0007269) | 3.40170657 |
26 | peptide cross-linking via chondroitin 4-sulfate glycosaminoglycan (GO:0019800) | 3.39276605 |
27 | adhesion of symbiont to host (GO:0044406) | 3.38783791 |
28 | regulation of glutamate receptor signaling pathway (GO:1900449) | 3.38380228 |
29 | endodermal cell differentiation (GO:0035987) | 3.36732075 |
30 | positive regulation of excitatory postsynaptic membrane potential (GO:2000463) | 3.35151881 |
31 | glutamate secretion (GO:0014047) | 3.33980018 |
32 | regulation of synaptic vesicle exocytosis (GO:2000300) | 3.31783257 |
33 | regulation of ryanodine-sensitive calcium-release channel activity (GO:0060314) | 3.29226826 |
34 | activation of protein kinase A activity (GO:0034199) | 3.29118569 |
35 | positive regulation of synaptic transmission, dopaminergic (GO:0032226) | 3.28731647 |
36 | regulation of vascular endothelial growth factor signaling pathway (GO:1900746) | 3.24370961 |
37 | regulation of cellular response to vascular endothelial growth factor stimulus (GO:1902547) | 3.23523164 |
38 | cardiac myofibril assembly (GO:0055003) | 3.22773522 |
39 | plasma membrane repair (GO:0001778) | 3.22761487 |
40 | regulation of ventricular cardiac muscle cell membrane repolarization (GO:0060307) | 3.21681817 |
41 | regulation of membrane repolarization (GO:0060306) | 3.20923579 |
42 | cell communication involved in cardiac conduction (GO:0086065) | 3.20339530 |
43 | negative regulation of potassium ion transmembrane transporter activity (GO:1901017) | 3.17105142 |
44 | neuromuscular process controlling posture (GO:0050884) | 3.16771863 |
45 | regulation of synaptic vesicle transport (GO:1902803) | 3.15915063 |
46 | fibril organization (GO:0097435) | 3.13567289 |
47 | negative regulation of potassium ion transmembrane transport (GO:1901380) | 3.13356284 |
48 | proline transport (GO:0015824) | 3.11734000 |
49 | synaptic vesicle docking involved in exocytosis (GO:0016081) | 3.11292865 |
50 | protein localization to synapse (GO:0035418) | 3.10410510 |
51 | regulation of atrial cardiac muscle cell membrane depolarization (GO:0060371) | 3.10341514 |
52 | positive regulation of potassium ion transmembrane transport (GO:1901381) | 3.07447340 |
53 | glomerular filtration (GO:0003094) | 3.04415781 |
54 | negative regulation of cytosolic calcium ion concentration (GO:0051481) | 3.04389684 |
55 | exploration behavior (GO:0035640) | 3.00686733 |
56 | neuronal action potential propagation (GO:0019227) | 2.98932553 |
57 | regulation of extracellular matrix disassembly (GO:0010715) | 2.98483237 |
58 | regulation of cell communication by electrical coupling (GO:0010649) | 2.97854370 |
59 | NADH metabolic process (GO:0006734) | 2.93645087 |
60 | renal filtration (GO:0097205) | 2.93000916 |
61 | sodium ion export (GO:0071436) | 2.92995658 |
62 | cellular potassium ion homeostasis (GO:0030007) | 2.92552830 |
63 | regulation of N-methyl-D-aspartate selective glutamate receptor activity (GO:2000310) | 2.90319874 |
64 | neurotransmitter transport (GO:0006836) | 2.89421526 |
65 | positive regulation of calcium ion transmembrane transporter activity (GO:1901021) | 2.88895623 |
66 | ethanol oxidation (GO:0006069) | 2.88414010 |
67 | protein carboxylation (GO:0018214) | 2.88168611 |
68 | peptidyl-glutamic acid carboxylation (GO:0017187) | 2.88168611 |
69 | detection of calcium ion (GO:0005513) | 2.88136112 |
70 | positive regulation of lipoprotein lipase activity (GO:0051006) | 2.87620577 |
71 | positive regulation of triglyceride lipase activity (GO:0061365) | 2.87620577 |
72 | chondrocyte proliferation (GO:0035988) | 2.86913766 |
73 | cardiac muscle contraction (GO:0060048) | 2.86532836 |
74 | membrane depolarization during action potential (GO:0086010) | 2.86423945 |
75 | regulation of plasminogen activation (GO:0010755) | 2.86349819 |
76 | triglyceride catabolic process (GO:0019433) | 2.84789277 |
77 | regulation of calcium ion transmembrane transporter activity (GO:1901019) | 2.84156250 |
78 | regulation of calcium ion transmembrane transport (GO:1903169) | 2.84156250 |
79 | regulation of neuronal synaptic plasticity (GO:0048168) | 2.82091735 |
80 | regulation of systemic arterial blood pressure by renin-angiotensin (GO:0003081) | 2.78697835 |
81 | ionotropic glutamate receptor signaling pathway (GO:0035235) | 2.77380458 |
82 | collagen fibril organization (GO:0030199) | 2.76613130 |
83 | sarcomere organization (GO:0045214) | 2.76373304 |
84 | melanin biosynthetic process (GO:0042438) | 2.76159524 |
85 | regulation of apoptotic cell clearance (GO:2000425) | 2.75831703 |
86 | potassium ion import (GO:0010107) | 2.75207944 |
87 | neuron cell-cell adhesion (GO:0007158) | 2.75168368 |
88 | vascular endothelial growth factor signaling pathway (GO:0038084) | 2.74968942 |
89 | apoptotic cell clearance (GO:0043277) | 2.74603579 |
90 | extracellular matrix assembly (GO:0085029) | 2.73843089 |
91 | neurological system process involved in regulation of systemic arterial blood pressure (GO:0001976) | 2.73235380 |
92 | lung vasculature development (GO:0060426) | 2.72923430 |
93 | acylglycerol catabolic process (GO:0046464) | 2.72833131 |
94 | neutral lipid catabolic process (GO:0046461) | 2.72833131 |
95 | hemidesmosome assembly (GO:0031581) | 2.72489665 |
96 | regulation of neurotransmitter levels (GO:0001505) | 2.71178325 |
97 | regulation of long-term neuronal synaptic plasticity (GO:0048169) | 2.70782024 |
98 | myofibril assembly (GO:0030239) | 2.69844598 |
99 | neurotransmitter catabolic process (GO:0042135) | 2.68879837 |
100 | cerebellar Purkinje cell differentiation (GO:0021702) | 2.67827980 |
101 | sequestering of extracellular ligand from receptor (GO:0035581) | 2.67456275 |
102 | regulation of actin filament-based movement (GO:1903115) | 2.65957548 |
103 | potassium ion homeostasis (GO:0055075) | 2.65206324 |
104 | positive regulation of potassium ion transport (GO:0043268) | 2.64207915 |
105 | regulation of voltage-gated calcium channel activity (GO:1901385) | 2.61759373 |
106 | regulation of relaxation of muscle (GO:1901077) | 2.61467021 |
107 | cellular response to vascular endothelial growth factor stimulus (GO:0035924) | 2.61015448 |
108 | type B pancreatic cell proliferation (GO:0044342) | 2.59272155 |
109 | layer formation in cerebral cortex (GO:0021819) | 2.58695130 |
110 | neuronal ion channel clustering (GO:0045161) | 2.58370895 |
111 | neuron-neuron synaptic transmission (GO:0007270) | 2.57221438 |
112 | gamma-aminobutyric acid transport (GO:0015812) | 2.57211699 |
113 | regulation of inhibitory postsynaptic membrane potential (GO:0060080) | 2.57168477 |
114 | keratan sulfate catabolic process (GO:0042340) | 2.57121981 |
115 | regulation of cholesterol homeostasis (GO:2000188) | 2.56710956 |
116 | mating behavior (GO:0007617) | 2.56124046 |
117 | neurotransmitter-gated ion channel clustering (GO:0072578) | 2.55580390 |
118 | multicellular organismal macromolecule metabolic process (GO:0044259) | 2.55502543 |
119 | collagen metabolic process (GO:0032963) | 2.54955761 |
120 | neuron recognition (GO:0008038) | 2.54386968 |
121 | complement activation, classical pathway (GO:0006958) | 2.54293618 |
122 | long-term memory (GO:0007616) | 2.52265901 |
123 | cGMP-mediated signaling (GO:0019934) | 2.51791245 |
124 | ventricular cardiac muscle cell action potential (GO:0086005) | 2.51248610 |
125 | protein retention in ER lumen (GO:0006621) | 2.50561171 |
126 | regulation of synaptic transmission, dopaminergic (GO:0032225) | 2.49982260 |
127 | cell-substrate junction assembly (GO:0007044) | 2.49569768 |
128 | synaptic transmission, glutamatergic (GO:0035249) | 2.49113674 |
129 | glycine transport (GO:0015816) | 2.48636048 |
130 | striatum development (GO:0021756) | 2.48602433 |
131 | regulation of heart rate by cardiac conduction (GO:0086091) | 2.48280486 |
132 | sarcoplasmic reticulum calcium ion transport (GO:0070296) | 2.47711852 |
133 | extracellular matrix disassembly (GO:0022617) | 2.47463335 |
134 | multicellular organismal metabolic process (GO:0044236) | 2.47115837 |
135 | cellular sodium ion homeostasis (GO:0006883) | 2.47002155 |
136 | cardiac conduction (GO:0061337) | 2.46902957 |
137 | regulation of excitatory postsynaptic membrane potential (GO:0060079) | 2.45844445 |
138 | positive regulation of sodium ion transport (GO:0010765) | 2.45221836 |
139 | dendritic spine morphogenesis (GO:0060997) | 2.44689988 |
140 | glutamate receptor signaling pathway (GO:0007215) | 2.44559497 |
141 | positive regulation of endothelial cell apoptotic process (GO:2000353) | 2.44498161 |
142 | collagen catabolic process (GO:0030574) | 2.44212068 |
143 | tricarboxylic acid cycle (GO:0006099) | 2.43623661 |
144 | multicellular organismal catabolic process (GO:0044243) | 2.43559081 |
145 | growth hormone secretion (GO:0030252) | 2.43498350 |
146 | melanin metabolic process (GO:0006582) | 2.43096682 |
147 | negative regulation of potassium ion transport (GO:0043267) | 2.42020779 |
148 | negative regulation of smooth muscle cell migration (GO:0014912) | 2.41636072 |
149 | regulation of potassium ion transmembrane transport (GO:1901379) | 2.41455816 |
150 | regulation of vesicle fusion (GO:0031338) | 2.41218635 |
151 | regulation of respiratory gaseous exchange by neurological system process (GO:0002087) | 2.40853164 |
152 | positive regulation of pseudopodium assembly (GO:0031274) | 2.40342508 |
153 | synaptic vesicle endocytosis (GO:0048488) | 2.39981892 |
154 | negative regulation of fatty acid transport (GO:2000192) | 2.39686930 |
155 | regulation of postsynaptic membrane potential (GO:0060078) | 2.39186155 |
156 | positive regulation of synaptic transmission, GABAergic (GO:0032230) | 2.38082756 |
157 | diacylglycerol metabolic process (GO:0046339) | 2.36185318 |
158 | negative regulation of phosphatidylinositol 3-kinase signaling (GO:0014067) | 2.36065120 |
159 | skin morphogenesis (GO:0043589) | 2.34710525 |
160 | ethanol metabolic process (GO:0006067) | 2.34709111 |
161 | regulation of metalloenzyme activity (GO:0048552) | 2.34294025 |
162 | plasma lipoprotein particle clearance (GO:0034381) | 2.33966344 |
163 | transcytosis (GO:0045056) | 2.33041825 |
164 | positive regulation of extracellular matrix organization (GO:1903055) | 2.32802290 |
165 | maintenance of protein localization in endoplasmic reticulum (GO:0035437) | 2.31508928 |
166 | muscle cell migration (GO:0014812) | 2.30850693 |
167 | angiotensin maturation (GO:0002003) | 2.29414320 |
168 | regulation of pseudopodium assembly (GO:0031272) | 2.29260553 |
169 | negative regulation of chondrocyte differentiation (GO:0032331) | 2.27892196 |
170 | actin filament depolymerization (GO:0030042) | 2.27767118 |
171 | positive regulation of membrane protein ectodomain proteolysis (GO:0051044) | 2.27009312 |
172 | chondroitin sulfate catabolic process (GO:0030207) | 2.26684824 |
173 | endocardial cushion development (GO:0003197) | 2.23726506 |
174 | endothelial cell morphogenesis (GO:0001886) | 2.22362564 |
175 | adherens junction assembly (GO:0034333) | 2.21757013 |
176 | COPI coating of Golgi vesicle (GO:0048205) | 2.20932686 |
177 | Golgi transport vesicle coating (GO:0048200) | 2.20932686 |
178 | cellular response to prostaglandin stimulus (GO:0071379) | 2.20535014 |
179 | regulation of cholesterol storage (GO:0010885) | 2.20498730 |
180 | regulation of complement activation (GO:0030449) | 2.19652254 |
181 | cell proliferation involved in metanephros development (GO:0072203) | 2.19646614 |
182 | triglyceride-rich lipoprotein particle remodeling (GO:0034370) | 2.19003909 |
183 | L-serine transport (GO:0015825) | 2.18954295 |
184 | venous blood vessel morphogenesis (GO:0048845) | 2.17901136 |
185 | peptidyl-proline hydroxylation (GO:0019511) | 2.17642892 |
186 | intestinal absorption (GO:0050892) | 2.17450114 |
187 | complement activation (GO:0006956) | 2.16494082 |
188 | secondary metabolite biosynthetic process (GO:0044550) | 2.16228823 |
189 | metanephric mesenchyme development (GO:0072075) | 2.15832355 |
190 | positive regulation of receptor recycling (GO:0001921) | 2.15616939 |
191 | negative regulation of cartilage development (GO:0061037) | 2.15551976 |
192 | stress fiber assembly (GO:0043149) | 2.15423615 |
193 | retina vasculature morphogenesis in camera-type eye (GO:0061299) | 2.12804148 |
194 | regulation of glycogen (starch) synthase activity (GO:2000465) | 2.12405750 |
195 | regulation of protein activation cascade (GO:2000257) | 2.11859338 |
196 | regulation of membrane protein ectodomain proteolysis (GO:0051043) | 2.10676348 |
197 | negative regulation of catenin import into nucleus (GO:0035414) | 2.08604276 |
198 | positive regulation of fatty acid beta-oxidation (GO:0032000) | 2.07712293 |
199 | epithelial cell-cell adhesion (GO:0090136) | 2.07569985 |
Rank | Gene Set | Z-score |
---|---|---|
1 | EZH2_22144423_ChIP-Seq_EOC_Human | 5.05948234 |
2 | TP63_17297297_ChIP-ChIP_HaCaT_Human | 3.56454630 |
3 | SUZ12_18555785_ChIP-Seq_MESCs_Mouse | 3.02170661 |
4 | * SUZ12_18692474_ChIP-Seq_MESCs_Mouse | 2.89622074 |
5 | GBX2_23144817_ChIP-Seq_PC3_Human | 2.74510782 |
6 | EZH2_18974828_ChIP-Seq_MESCs_Mouse | 2.68421627 |
7 | RNF2_18974828_ChIP-Seq_MESCs_Mouse | 2.68421627 |
8 | ESR1_17901129_ChIP-ChIP_LIVER_Mouse | 2.64500318 |
9 | JARID2_20064375_ChIP-Seq_MESCs_Mouse | 2.56493175 |
10 | SUZ12_18692474_ChIP-Seq_MEFs_Mouse | 2.51871010 |
11 | SUZ12_18974828_ChIP-Seq_MESCs_Mouse | 2.45856513 |
12 | * CLOCK_20551151_ChIP-Seq_293T_Human | 2.44875667 |
13 | * MTF2_20144788_ChIP-Seq_MESCs_Mouse | 2.43528890 |
14 | * JARID2_20075857_ChIP-Seq_MESCs_Mouse | 2.43002974 |
15 | DROSHA_22980978_ChIP-Seq_HELA_Human | 2.39951754 |
16 | * SUZ12_16625203_ChIP-ChIP_MESCs_Mouse | 2.39348633 |
17 | * TCF21_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 2.37395677 |
18 | * SUZ12_20075857_ChIP-Seq_MESCs_Mouse | 2.32752824 |
19 | EZH2_27304074_Chip-Seq_ESCs_Mouse | 2.28429820 |
20 | EED_16625203_ChIP-ChIP_MESCs_Mouse | 2.25237632 |
21 | LXR_22292898_ChIP-Seq_THP-1_Human | 2.21413839 |
22 | * EZH2_27294783_Chip-Seq_ESCs_Mouse | 2.09322699 |
23 | * SUZ12_27294783_Chip-Seq_ESCs_Mouse | 2.06407155 |
24 | ELK3_25401928_ChIP-Seq_HUVEC_Human | 1.97715673 |
25 | RNF2_27304074_Chip-Seq_ESCs_Mouse | 1.92232788 |
26 | AR_21572438_ChIP-Seq_LNCaP_Human | 1.90777970 |
27 | RXR_22158963_ChIP-Seq_LIVER_Mouse | 1.87302148 |
28 | IKZF1_21737484_ChIP-ChIP_HCT116_Human | 1.86724779 |
29 | REST_21632747_ChIP-Seq_MESCs_Mouse | 1.85933019 |
30 | RUNX2_24764292_ChIP-Seq_MC3T3_Mouse | 1.81488457 |
31 | TCF21_23034159_ChIP-ChIP_E13_GONADS_Rat | 1.79338899 |
32 | * RARB_27405468_Chip-Seq_BRAIN_Mouse | 1.78889654 |
33 | EP300_21415370_ChIP-Seq_HL-1_Mouse | 1.77645049 |
34 | CDX2_19796622_ChIP-Seq_MESCs_Mouse | 1.70173041 |
35 | MYCN_19997598_ChIP-ChIP_NEUROBLASTOMA_Human | 1.67524363 |
36 | TRIM28_21343339_ChIP-Seq_HEK293_Human | 1.64523591 |
37 | TAF7L_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.64391922 |
38 | * REST_18959480_ChIP-ChIP_MESCs_Mouse | 1.62164904 |
39 | ESRRB_18555785_ChIP-Seq_MESCs_Mouse | 1.60759383 |
40 | * KDM2B_26808549_Chip-Seq_SUP-B15_Human | 1.60397310 |
41 | PPARA_22158963_ChIP-Seq_LIVER_Mouse | 1.53382191 |
42 | CDKN2AIP_20523734_ChIP-Seq_CORTICAL_Neurons | 1.51373873 |
43 | RACK7_27058665_Chip-Seq_MCF-7_Human | 1.50213948 |
44 | NUCKS1_24931609_ChIP-Seq_HEPATOCYTES_Mouse | 1.48435587 |
45 | SOX9_25088423_ChIP-ChIP_EMBRYONIC_GONADS_Mouse | 1.48165073 |
46 | LXR_22158963_ChIP-Seq_LIVER_Mouse | 1.47669241 |
47 | ESR1_22446102_ChIP-Seq_UTERUS_Mouse | 1.47192912 |
48 | GLI1_17442700_ChIP-ChIP_MESCs_Mouse | 1.45845724 |
49 | ERG_21242973_ChIP-ChIP_JURKAT_Human | 1.45421487 |
50 | UBF1/2_26484160_Chip-Seq_HMEC-DERIVED_Human | 1.44954785 |
51 | NR3C1_23031785_ChIP-Seq_PC12_Mouse | 1.44097806 |
52 | EZH2_23942234_ChIP-Seq_MYOBLASTS_AND_MYOTUBES_Mouse | 1.43644918 |
53 | FOXO1_23066095_ChIP-Seq_LIVER_Mouse | 1.43638640 |
54 | CEBPB_21427703_ChIP-Seq_3T3-L1_Mouse | 1.41435557 |
55 | ZNF263_19887448_ChIP-Seq_K562_Human | 1.40824004 |
56 | SMAD4_21799915_ChIP-Seq_A2780_Human | 1.39055237 |
57 | NFIB_24661679_ChIP-Seq_LUNG_Mouse | 1.38743100 |
58 | ESR1_21235772_ChIP-Seq_MCF-7_Human | 1.37505997 |
59 | PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 1.33843344 |
60 | SMC1_22415368_ChIP-Seq_MEFs_Mouse | 1.32883385 |
61 | CTBP2_25329375_ChIP-Seq_LNCAP_Human | 1.32079479 |
62 | SMC3_22415368_ChIP-Seq_MEFs_Mouse | 1.31484597 |
63 | PAX3-FKHR_20663909_ChIP-Seq_RHABDOMYOSARCOMA_Human | 1.30644908 |
64 | SRY_25088423_ChIP-ChIP_EMBRYONIC_GONADS_Mouse | 1.29988091 |
65 | PHC1_16625203_ChIP-ChIP_MESCs_Mouse | 1.29854236 |
66 | NR1I2_20693526_ChIP-Seq_LIVER_Mouse | 1.29040558 |
67 | GATA2_21666600_ChIP-Seq_HMVEC_Human | 1.27850363 |
68 | * RING1B_27294783_Chip-Seq_ESCs_Mouse | 1.26292263 |
69 | CTBP1_25329375_ChIP-Seq_LNCAP_Human | 1.25001752 |
70 | TFAP2C_20629094_ChIP-Seq_MCF-7_Human | 1.21805437 |
71 | PBX_27287812_Chip-Seq_EMBYONIC-LIMB_Mouse | 1.21561241 |
72 | P63_26484246_Chip-Seq_KERATINOCYTES_Human | 1.21406591 |
73 | PIAS1_25552417_ChIP-Seq_VCAP_Human | 1.19981533 |
74 | TAF15_26573619_Chip-Seq_HEK293_Human | 1.19752600 |
75 | * WT1_25993318_ChIP-Seq_PODOCYTE_Human | 1.19284563 |
76 | SOX2_21211035_ChIP-Seq_LN229_Gbm | 1.18599363 |
77 | * RAD21_21589869_ChIP-Seq_MESCs_Mouse | 1.18221005 |
78 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 1.18207311 |
79 | NR0B1_18358816_ChIP-ChIP_MESCs_Mouse | 1.17230807 |
80 | * DNAJC2_21179169_ChIP-ChIP_NT2_Human | 1.15994455 |
81 | NR4A2_19515692_ChIP-ChIP_MN9D_Mouse | 1.15098320 |
82 | RNF2_16625203_ChIP-ChIP_MESCs_Mouse | 1.14943872 |
83 | BACH1_22875853_ChIP-PCR_HELA_AND_SCP4_Human | 1.14175999 |
84 | SMAD2/3_21741376_ChIP-Seq_EPCs_Human | 1.14112787 |
85 | ZNF652_21678463_ChIP-ChIP_ZR75-1_Human | 1.12765397 |
86 | KDM2B_26808549_Chip-Seq_K562_Human | 1.11151750 |
87 | ZNF274_21170338_ChIP-Seq_K562_Hela | 1.10943435 |
88 | STAT6_21828071_ChIP-Seq_BEAS2B_Human | 1.09836593 |
89 | P300_27058665_Chip-Seq_ZR-75-30cells_Human | 1.09479576 |
90 | ESR1_20079471_ChIP-ChIP_T-47D_Human | 1.09356419 |
91 | SMAD3_22036565_ChIP-Seq_ESCs_Mouse | 1.09172103 |
92 | HIF1A_21447827_ChIP-Seq_MCF-7_Human | 1.08931044 |
93 | AR_19668381_ChIP-Seq_PC3_Human | 1.08053479 |
94 | TP53_22127205_ChIP-Seq_IMR90_Human | 1.07918256 |
95 | ZNF217_24962896_ChIP-Seq_MCF-7_Human | 1.07785821 |
96 | AHR_22903824_ChIP-Seq_MCF-7_Human | 1.06478576 |
97 | * PRDM16_22522345_ChIP-ChIP_PALATE_MESENCHYMAL_Mouse | 1.06428550 |
98 | RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 1.06081851 |
99 | * TET1_21490601_ChIP-Seq_MESCs_Mouse | 1.04454865 |
100 | SOX9_24532713_ChIP-Seq_HFSC_Mouse | 1.03906972 |
101 | WT1_20215353_ChIP-ChIP_NEPHRON_PROGENITOR_Mouse | 1.03854695 |
102 | * EGR1_20690147_ChIP-Seq_ERYTHROLEUKEMIA_Human | 1.03242165 |
103 | TBP_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.03188574 |
104 | ZFP281_18757296_ChIP-ChIP_E14_Mouse | 1.02646295 |
105 | SMARCD1_25818293_ChIP-Seq_ESCs_Mouse | 1.02543670 |
106 | CTCF_27219007_Chip-Seq_Bcells_Human | 1.02516668 |
107 | ESR2_21235772_ChIP-Seq_MCF-7_Human | 1.02445045 |
108 | CJUN_26792858_Chip-Seq_BT549_Human | 1.02126706 |
109 | AR_25329375_ChIP-Seq_VCAP_Human | 1.01781630 |
110 | TOP2B_26459242_ChIP-Seq_MCF-7_Human | 1.01390228 |
111 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 1.01124006 |
112 | TET1_21451524_ChIP-Seq_MESCs_Mouse | 1.00906499 |
113 | CDX2_20551321_ChIP-Seq_CACO-2_Human | 1.00387373 |
114 | SMAD4_21741376_ChIP-Seq_HESCs_Human | 1.00334878 |
115 | KLF6_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.00265492 |
116 | ZFP281_18358816_ChIP-ChIP_MESCs_Mouse | 1.00214710 |
117 | SA1_27219007_Chip-Seq_ERYTHROID_Human | 0.98791598 |
118 | TCF3/E2A_22897851_ChIP-Seq_JUKARTE6-1_Human | 0.98489357 |
119 | ARNT_22903824_ChIP-Seq_MCF-7_Human | 0.98286533 |
120 | BCAT_22108803_ChIP-Seq_LS180_Human | 0.98080963 |
121 | KDM2B_26808549_Chip-Seq_DND41_Human | 0.96993618 |
122 | KLF4_26769127_Chip-Seq_PDAC-Cell_line_Human | 0.96149050 |
123 | * SMC4_20622854_ChIP-Seq_HELA_Human | 0.96145798 |
124 | SMAD3_21741376_ChIP-Seq_EPCs_Human | 0.95891824 |
125 | TRP63_18441228_ChIP-ChIP_KERATINOCYTES_Mouse | 0.95563772 |
126 | P300_19829295_ChIP-Seq_ESCs_Human | 0.95455784 |
127 | KDM2B_26808549_Chip-Seq_SIL-ALL_Human | 0.95416200 |
128 | MEIS1_26923725_Chip-Seq_HEMOGENIC-ENDOTHELIUM_Mouse | 0.95266554 |
129 | SA1_22415368_ChIP-Seq_MEFs_Mouse | 0.95258804 |
130 | TP53_23651856_ChIP-Seq_MEFs_Mouse | 0.95176424 |
131 | STAT3_19079543_ChIP-ChIP_MESCs_Mouse | 0.95080569 |
132 | CTCF_27219007_Chip-Seq_ERYTHROID_Human | 0.95034103 |
133 | SMARCA4_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 0.94797480 |
134 | PPARD_23176727_ChIP-Seq_KERATINOCYTES_Mouse | 0.93636044 |
135 | RARG_19884340_ChIP-ChIP_MEFs_Mouse | 0.92258392 |
136 | PPAR_26484153_Chip-Seq_NCI-H1993_Human | 0.92160292 |
137 | * FOXA2_19822575_ChIP-Seq_HepG2_Human | 0.92106547 |
138 | * RING1B_27294783_Chip-Seq_NPCs_Mouse | 0.92041794 |
139 | CBX2_27304074_Chip-Seq_ESCs_Mouse | 0.91794651 |
140 | STAT3_23295773_ChIP-Seq_U87_Human | 0.91039493 |
141 | SMAD_19615063_ChIP-ChIP_OVARY_Human | 0.91019858 |
142 | TP63_22573176_ChIP-Seq_HFKS_Human | 0.90227942 |
143 | EP300_20729851_ChIP-Seq_FORBRAIN_MIDBRAIN_LIMB_HEART_Mouse | 0.89877593 |
144 | GATA2_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 0.89123208 |
145 | TP53_16413492_ChIP-PET_HCT116_Human | 0.87249870 |
146 | RCOR3_21632747_ChIP-Seq_MESCs_Mouse | 0.87237573 |
147 | SMAD3_21741376_ChIP-Seq_HESCs_Human | 0.87208127 |
148 | ZFP57_27257070_Chip-Seq_ESCs_Mouse | 0.87064809 |
149 | NR3C1_21868756_ChIP-Seq_MCF10A_Human | 0.85225770 |
150 | BMI1_23680149_ChIP-Seq_NPCS_Mouse | 0.85180370 |
151 | * TBX20_22080862_ChIP-Seq_HEART_Mouse | 0.85036167 |
152 | * TBX20_22328084_ChIP-Seq_HEART_Mouse | 0.85036167 |
153 | ZFP322A_24550733_ChIP-Seq_MESCs_Mouse | 0.84636435 |
154 | OLIG2_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 0.84295020 |
155 | UBF1/2_26484160_Chip-Seq_FIBROBLAST_Human | 0.83989896 |
156 | TP53_20018659_ChIP-ChIP_R1E_Mouse | 0.83428957 |
157 | TP53_18474530_ChIP-ChIP_U2OS_Human | 0.83126642 |
158 | TAL1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 0.82421655 |
159 | AR_22383394_ChIP-Seq_PROSTATE_CANCER_Human | 0.80154897 |
160 | TRIM28_17542650_ChIP-ChIP_NTERA2_Human | 0.79600397 |
Rank | Gene Set | Z-score |
---|---|---|
1 | MP0004859_abnormal_synaptic_plasticity | 4.08206789 |
2 | MP0002837_dystrophic_cardiac_calcinosis | 4.02023748 |
3 | MP0005257_abnormal_intraocular_pressure | 3.86574728 |
4 | MP0000751_myopathy | 3.70320020 |
5 | MP0002822_catalepsy | 3.30611612 |
6 | MP0003705_abnormal_hypodermis_morpholog | 3.28136971 |
7 | MP0005409_darkened_coat_color | 2.81326598 |
8 | MP0003635_abnormal_synaptic_transmissio | 2.75691877 |
9 | MP0003880_abnormal_central_pattern | 2.73364346 |
10 | MP0008438_abnormal_cutaneous_collagen | 2.69065297 |
11 | MP0003646_muscle_fatigue | 2.64426674 |
12 | MP0004215_abnormal_myocardial_fiber | 2.52014744 |
13 | MP0005503_abnormal_tendon_morphology | 2.51487131 |
14 | MP0005171_absent_coat_pigmentation | 2.50559483 |
15 | MP0004084_abnormal_cardiac_muscle | 2.40388652 |
16 | MP0009046_muscle_twitch | 2.34131400 |
17 | MP0009745_abnormal_behavioral_response | 2.30704478 |
18 | MP0005275_abnormal_skin_tensile | 2.21519255 |
19 | MP0002064_seizures | 2.18974903 |
20 | MP0004036_abnormal_muscle_relaxation | 2.16447746 |
21 | MP0001501_abnormal_sleep_pattern | 2.14865743 |
22 | MP0009840_abnormal_foam_cell | 2.11137738 |
23 | MP0002063_abnormal_learning/memory/cond | 2.02795113 |
24 | MP0002272_abnormal_nervous_system | 1.96040477 |
25 | MP0004270_analgesia | 1.94292118 |
26 | MP0005360_urolithiasis | 1.86108563 |
27 | MP0003566_abnormal_cell_adhesion | 1.85909211 |
28 | MP0006276_abnormal_autonomic_nervous | 1.84475380 |
29 | MP0002572_abnormal_emotion/affect_behav | 1.83440363 |
30 | MP0005330_cardiomyopathy | 1.82685181 |
31 | MP0000749_muscle_degeneration | 1.74339714 |
32 | MP0002909_abnormal_adrenal_gland | 1.72807283 |
33 | MP0004085_abnormal_heartbeat | 1.71731448 |
34 | MP0005058_abnormal_lysosome_morphology | 1.71633174 |
35 | MP0001968_abnormal_touch/_nociception | 1.66888480 |
36 | MP0004858_abnormal_nervous_system | 1.65393529 |
37 | MP0002734_abnormal_mechanical_nocicepti | 1.63973526 |
38 | MP0004145_abnormal_muscle_electrophysio | 1.62038968 |
39 | MP0001440_abnormal_grooming_behavior | 1.60688757 |
40 | MP0003137_abnormal_impulse_conducting | 1.58510976 |
41 | MP0002735_abnormal_chemical_nociception | 1.57155022 |
42 | MP0004130_abnormal_muscle_cell | 1.56425523 |
43 | MP0005620_abnormal_muscle_contractility | 1.55118787 |
44 | MP0006054_spinal_hemorrhage | 1.53558872 |
45 | MP0008775_abnormal_heart_ventricle | 1.53046992 |
46 | MP0004484_altered_response_of | 1.52932184 |
47 | MP0000013_abnormal_adipose_tissue | 1.52651029 |
48 | MP0002972_abnormal_cardiac_muscle | 1.52232636 |
49 | MP0005423_abnormal_somatic_nervous | 1.51682886 |
50 | MP0008569_lethality_at_weaning | 1.51219826 |
51 | MP0001486_abnormal_startle_reflex | 1.50610870 |
52 | MP0010329_abnormal_lipoprotein_level | 1.50090926 |
53 | MP0000767_abnormal_smooth_muscle | 1.49574364 |
54 | MP0002933_joint_inflammation | 1.48838143 |
55 | MP0004924_abnormal_behavior | 1.48354610 |
56 | MP0005386_behavior/neurological_phenoty | 1.48354610 |
57 | MP0002108_abnormal_muscle_morphology | 1.46069544 |
58 | MP0001958_emphysema | 1.45577066 |
59 | MP0005508_abnormal_skeleton_morphology | 1.44597715 |
60 | MP0009780_abnormal_chondrocyte_physiolo | 1.43231813 |
61 | MP0001542_abnormal_bone_strength | 1.42105946 |
62 | MP0003136_yellow_coat_color | 1.41516304 |
63 | MP0002060_abnormal_skin_morphology | 1.38542090 |
64 | MP0002733_abnormal_thermal_nociception | 1.36914424 |
65 | MP0004087_abnormal_muscle_fiber | 1.35027362 |
66 | MP0005666_abnormal_adipose_tissue | 1.34528623 |
67 | MP0006138_congestive_heart_failure | 1.34006177 |
68 | MP0001970_abnormal_pain_threshold | 1.33845788 |
69 | MP0002295_abnormal_pulmonary_circulatio | 1.33553456 |
70 | MP0002067_abnormal_sensory_capabilities | 1.32870010 |
71 | MP0010386_abnormal_urinary_bladder | 1.32807310 |
72 | MP0002896_abnormal_bone_mineralization | 1.30866017 |
73 | MP0001849_ear_inflammation | 1.28201651 |
74 | MP0002971_abnormal_brown_adipose | 1.27914679 |
75 | MP0000747_muscle_weakness | 1.27753971 |
76 | MP0005023_abnormal_wound_healing | 1.25888442 |
77 | MP0002736_abnormal_nociception_after | 1.22227818 |
78 | MP0009384_cardiac_valve_regurgitation | 1.21582959 |
79 | MP0001544_abnormal_cardiovascular_syste | 1.20372514 |
80 | MP0005385_cardiovascular_system_phenoty | 1.20372514 |
81 | MP0003122_maternal_imprinting | 1.18088810 |
82 | MP0005623_abnormal_meninges_morphology | 1.17957903 |
83 | MP0004233_abnormal_muscle_weight | 1.17803463 |
84 | MP0005369_muscle_phenotype | 1.17559956 |
85 | MP0003279_aneurysm | 1.16841460 |
86 | MP0003091_abnormal_cell_migration | 1.16798807 |
87 | MP0000604_amyloidosis | 1.15276410 |
88 | MP0002184_abnormal_innervation | 1.13535905 |
89 | MP0005595_abnormal_vascular_smooth | 1.11688755 |
90 | MP0002106_abnormal_muscle_physiology | 1.11306502 |
91 | MP0002139_abnormal_hepatobiliary_system | 1.09505053 |
92 | MP0005408_hypopigmentation | 1.09455784 |
93 | MP0001879_abnormal_lymphatic_vessel | 1.08645285 |
94 | MP0003329_amyloid_beta_deposits | 1.07242122 |
95 | MP0000759_abnormal_skeletal_muscle | 1.06689249 |
96 | MP0010368_abnormal_lymphatic_system | 1.06214989 |
97 | MP0000015_abnormal_ear_pigmentation | 1.05636571 |
98 | MP0002557_abnormal_social/conspecific_i | 1.05548672 |
99 | MP0005535_abnormal_body_temperature | 1.03392395 |
100 | MP0002877_abnormal_melanocyte_morpholog | 1.01722910 |
101 | MP0003950_abnormal_plasma_membrane | 1.00412183 |
102 | MP0000750_abnormal_muscle_regeneration | 1.00301210 |
103 | MP0001529_abnormal_vocalization | 0.99916512 |
104 | MP0002269_muscular_atrophy | 0.99301242 |
105 | MP0001905_abnormal_dopamine_level | 0.98870188 |
106 | MP0004272_abnormal_basement_membrane | 0.98101644 |
107 | MP0002998_abnormal_bone_remodeling | 0.97506008 |
108 | MP0005365_abnormal_bile_salt | 0.97413172 |
109 | MP0002066_abnormal_motor_capabilities/c | 0.96951343 |
110 | MP0000343_altered_response_to | 0.96579559 |
111 | MP0004811_abnormal_neuron_physiology | 0.95820729 |
112 | MP0003633_abnormal_nervous_system | 0.95650199 |
113 | MP0002089_abnormal_postnatal_growth/wei | 0.95334827 |
114 | MP0000003_abnormal_adipose_tissue | 0.94683822 |
115 | MP0001502_abnormal_circadian_rhythm | 0.93678393 |
116 | MP0004142_abnormal_muscle_tone | 0.92509778 |
117 | MP0005164_abnormal_response_to | 0.92036526 |
118 | MP0005390_skeleton_phenotype | 0.91441004 |
119 | MP0003879_abnormal_hair_cell | 0.89783577 |
120 | MP0000249_abnormal_blood_vessel | 0.88511383 |
121 | MP0008874_decreased_physiological_sensi | 0.88009048 |
122 | MP0005551_abnormal_eye_electrophysiolog | 0.87853659 |
123 | MP0000230_abnormal_systemic_arterial | 0.87341981 |
124 | MP0000372_irregular_coat_pigmentation | 0.87102009 |
125 | MP0002882_abnormal_neuron_morphology | 0.87058596 |
126 | MP0004510_myositis | 0.86917229 |
127 | MP0005646_abnormal_pituitary_gland | 0.86571130 |
128 | MP0000762_abnormal_tongue_morphology | 0.86344374 |
129 | MP0000955_abnormal_spinal_cord | 0.85909759 |
130 | MP0002090_abnormal_vision | 0.85363093 |
131 | MP0000778_abnormal_nervous_system | 0.84437679 |
132 | MP0003191_abnormal_cellular_cholesterol | 0.83878562 |
133 | MP0005165_increased_susceptibility_to | 0.83785277 |
134 | MP0003172_abnormal_lysosome_physiology | 0.82552912 |
135 | MP0000733_abnormal_muscle_development | 0.81645166 |
136 | MP0008260_abnormal_autophagy | 0.80809728 |
137 | MP0005670_abnormal_white_adipose | 0.80015741 |
138 | MP0001299_abnormal_eye_distance/ | 0.79866485 |
139 | MP0001533_abnormal_skeleton_physiology | 0.79725588 |
140 | MP0005645_abnormal_hypothalamus_physiol | 0.79372850 |
141 | MP0002876_abnormal_thyroid_physiology | 0.77877623 |
142 | MP0005197_abnormal_uvea_morphology | 0.76898928 |
143 | MP0002638_abnormal_pupillary_reflex | 0.75306429 |
144 | MP0003868_abnormal_feces_composition | 0.75168082 |
145 | MP0000534_abnormal_ureter_morphology | 0.75020036 |
146 | MP0003011_delayed_dark_adaptation | 0.74315681 |
147 | MP0002127_abnormal_cardiovascular_syste | 0.73790413 |
148 | MP0001177_atelectasis | 0.73790203 |
149 | MP0005375_adipose_tissue_phenotype | 0.73580277 |
150 | MP0002332_abnormal_exercise_endurance | 0.72990671 |
151 | MP0010630_abnormal_cardiac_muscle | 0.72723909 |
152 | MP0004019_abnormal_vitamin_homeostasis | 0.72561918 |
153 | MP0003631_nervous_system_phenotype | 0.72013155 |
154 | MP0008961_abnormal_basal_metabolism | 0.71101647 |
155 | MP0002118_abnormal_lipid_homeostasis | 0.70912009 |
156 | MP0001243_abnormal_dermal_layer | 0.69852378 |
157 | MP0000163_abnormal_cartilage_morphology | 0.68459068 |
158 | MP0000371_diluted_coat_color | 0.66790249 |
159 | MP0005167_abnormal_blood-brain_barrier | 0.65858615 |
160 | MP0000678_abnormal_parathyroid_gland | 0.65713970 |
161 | MP0001614_abnormal_blood_vessel | 0.63267016 |
162 | MP0005451_abnormal_body_composition | 0.63254098 |
163 | MP0003075_altered_response_to | 0.62612950 |
Rank | Gene Set | Z-score |
---|---|---|
1 | Myokymia (HP:0002411) | 4.64342059 |
2 | Sudden death (HP:0001699) | 4.60973975 |
3 | Focal motor seizures (HP:0011153) | 4.35985122 |
4 | Vertebral compression fractures (HP:0002953) | 3.91661734 |
5 | Broad metatarsal (HP:0001783) | 3.73436567 |
6 | Atrial fibrillation (HP:0005110) | 3.69740933 |
7 | Focal seizures (HP:0007359) | 3.64680263 |
8 | Vascular tortuosity (HP:0004948) | 3.63539891 |
9 | Aortic dissection (HP:0002647) | 3.62320521 |
10 | Aortic aneurysm (HP:0004942) | 3.61933457 |
11 | Exercise-induced myalgia (HP:0003738) | 3.60730472 |
12 | Systemic lupus erythematosus (HP:0002725) | 3.54618856 |
13 | Calf muscle hypertrophy (HP:0008981) | 3.53870335 |
14 | Primary atrial arrhythmia (HP:0001692) | 3.53767184 |
15 | Complement deficiency (HP:0004431) | 3.51157819 |
16 | Prolonged QT interval (HP:0001657) | 3.39597792 |
17 | Supraventricular tachycardia (HP:0004755) | 3.36222762 |
18 | Ventricular fibrillation (HP:0001663) | 3.35986073 |
19 | Follicular hyperkeratosis (HP:0007502) | 3.35797375 |
20 | Muscle fiber splitting (HP:0003555) | 3.33885737 |
21 | Supraventricular arrhythmia (HP:0005115) | 3.33203362 |
22 | Atrophic scars (HP:0001075) | 3.31431259 |
23 | Abnormality of the calf musculature (HP:0001430) | 3.30755915 |
24 | Abnormality of complement system (HP:0005339) | 3.30327097 |
25 | Bundle branch block (HP:0011710) | 3.29248030 |
26 | Arterial tortuosity (HP:0005116) | 3.28979787 |
27 | Muscle hypertrophy of the lower extremities (HP:0008968) | 3.24838565 |
28 | Visual hallucinations (HP:0002367) | 3.15858705 |
29 | Myotonia (HP:0002486) | 3.12534294 |
30 | Soft skin (HP:0000977) | 3.10363830 |
31 | Cervical subluxation (HP:0003308) | 3.06799821 |
32 | Increased variability in muscle fiber diameter (HP:0003557) | 3.06552397 |
33 | Syncope (HP:0001279) | 3.04905913 |
34 | Pheochromocytoma (HP:0002666) | 3.03902732 |
35 | Fragile skin (HP:0001030) | 3.00148078 |
36 | Atonic seizures (HP:0010819) | 3.00004589 |
37 | Action tremor (HP:0002345) | 2.98838085 |
38 | Increased connective tissue (HP:0009025) | 2.97381581 |
39 | Ventricular tachycardia (HP:0004756) | 2.94763792 |
40 | Shallow orbits (HP:0000586) | 2.94383972 |
41 | Wormian bones (HP:0002645) | 2.90171592 |
42 | Hyporeflexia of lower limbs (HP:0002600) | 2.89404119 |
43 | Abnormal EKG (HP:0003115) | 2.78773049 |
44 | Slender build (HP:0001533) | 2.78049970 |
45 | Deep venous thrombosis (HP:0002625) | 2.74938521 |
46 | Exercise-induced muscle cramps (HP:0003710) | 2.73992907 |
47 | Blue sclerae (HP:0000592) | 2.69066008 |
48 | Ventricular arrhythmia (HP:0004308) | 2.68640198 |
49 | Round ear (HP:0100830) | 2.67611132 |
50 | Progressive cerebellar ataxia (HP:0002073) | 2.65369593 |
51 | Febrile seizures (HP:0002373) | 2.65243885 |
52 | Dysmetric saccades (HP:0000641) | 2.61794291 |
53 | Lipoatrophy (HP:0100578) | 2.61512202 |
54 | Neuroendocrine neoplasm (HP:0100634) | 2.60181360 |
55 | Right ventricular cardiomyopathy (HP:0011663) | 2.57771928 |
56 | Generalized tonic-clonic seizures (HP:0002069) | 2.57449311 |
57 | Type 1 muscle fiber predominance (HP:0003803) | 2.56852726 |
58 | Peritonitis (HP:0002586) | 2.54610862 |
59 | Difficulty running (HP:0009046) | 2.50157219 |
60 | Absence seizures (HP:0002121) | 2.49218346 |
61 | Abnormality of skeletal muscle fiber size (HP:0012084) | 2.48388567 |
62 | Palpitations (HP:0001962) | 2.48197228 |
63 | Protrusio acetabuli (HP:0003179) | 2.47358515 |
64 | EMG: myopathic abnormalities (HP:0003458) | 2.44410310 |
65 | Anxiety (HP:0000739) | 2.44319870 |
66 | Heart block (HP:0012722) | 2.41302970 |
67 | Torticollis (HP:0000473) | 2.40740154 |
68 | Epileptic encephalopathy (HP:0200134) | 2.36955350 |
69 | Hypoventilation (HP:0002791) | 2.36650447 |
70 | Skin nodule (HP:0200036) | 2.35471183 |
71 | Aneurysm (HP:0002617) | 2.35123556 |
72 | Abnormal atrioventricular conduction (HP:0005150) | 2.34501880 |
73 | Mitral stenosis (HP:0001718) | 2.33875747 |
74 | Xanthomatosis (HP:0000991) | 2.33346379 |
75 | Dilatation of the ascending aorta (HP:0005111) | 2.32630779 |
76 | Joint stiffness (HP:0001387) | 2.30484230 |
77 | Neonatal short-limb short stature (HP:0008921) | 2.29862367 |
78 | Hemorrhage of the eye (HP:0011885) | 2.29091163 |
79 | Central scotoma (HP:0000603) | 2.28219368 |
80 | Depression (HP:0000716) | 2.27830883 |
81 | Glomerulonephritis (HP:0000099) | 2.23764213 |
82 | Abnormality of dentin (HP:0010299) | 2.22936439 |
83 | Atrioventricular block (HP:0001678) | 2.20944240 |
84 | Myoglobinuria (HP:0002913) | 2.20503144 |
85 | Hyperextensible skin (HP:0000974) | 2.19774874 |
86 | Biconcave vertebral bodies (HP:0004586) | 2.19074337 |
87 | Dysdiadochokinesis (HP:0002075) | 2.18548233 |
88 | Thin bony cortex (HP:0002753) | 2.17632913 |
89 | Supranuclear gaze palsy (HP:0000605) | 2.16803350 |
90 | Mildly elevated creatine phosphokinase (HP:0008180) | 2.16059067 |
91 | Bradycardia (HP:0001662) | 2.16049170 |
92 | Upper limb amyotrophy (HP:0009129) | 2.14078628 |
93 | Distal upper limb amyotrophy (HP:0007149) | 2.14078628 |
94 | Ankle clonus (HP:0011448) | 2.13605860 |
95 | Genu recurvatum (HP:0002816) | 2.10984048 |
96 | Bladder diverticulum (HP:0000015) | 2.10649524 |
97 | Neurofibrillary tangles (HP:0002185) | 2.09390314 |
98 | Dialeptic seizures (HP:0011146) | 2.09346300 |
99 | Long toe (HP:0010511) | 2.09190715 |
100 | Postural instability (HP:0002172) | 2.08289677 |
101 | Joint laxity (HP:0001388) | 2.06426474 |
102 | Cardiovascular calcification (HP:0011915) | 2.06303806 |
103 | Cerebral aneurysm (HP:0004944) | 2.05803805 |
104 | Impaired social interactions (HP:0000735) | 2.03335321 |
105 | Abnormal social behavior (HP:0012433) | 2.03335321 |
106 | Achilles tendon contracture (HP:0001771) | 2.02642803 |
107 | Distal lower limb muscle weakness (HP:0009053) | 2.02019251 |
108 | Hypercortisolism (HP:0001578) | 2.01408637 |
109 | Asymmetric septal hypertrophy (HP:0001670) | 2.01320989 |
110 | Focal dystonia (HP:0004373) | 2.01158688 |
111 | Coxa vara (HP:0002812) | 2.00733661 |
112 | Left ventricular hypertrophy (HP:0001712) | 2.00654647 |
113 | Abnormality of the left ventricular outflow tract (HP:0011103) | 2.00182874 |
114 | Subaortic stenosis (HP:0001682) | 2.00182874 |
115 | Limb dystonia (HP:0002451) | 1.99178290 |
116 | Wrist flexion contracture (HP:0001239) | 1.98802325 |
117 | Acanthosis nigricans (HP:0000956) | 1.98468770 |
118 | Craniofacial dystonia (HP:0012179) | 1.97607394 |
119 | Elbow flexion contracture (HP:0002987) | 1.97467732 |
120 | Mitral valve prolapse (HP:0001634) | 1.97321784 |
121 | Premature rupture of membranes (HP:0001788) | 1.97252729 |
122 | Abnormality of the Achilles tendon (HP:0005109) | 1.96658745 |
123 | Abnormal eating behavior (HP:0100738) | 1.94574979 |
124 | Poor eye contact (HP:0000817) | 1.93170446 |
125 | Pulmonary artery stenosis (HP:0004415) | 1.92897643 |
126 | Dysostosis multiplex (HP:0000943) | 1.92730080 |
127 | Abnormality of glutamine family amino acid metabolism (HP:0010902) | 1.92656077 |
128 | Abnormality of proline metabolism (HP:0010907) | 1.91571186 |
129 | Hydroxyprolinuria (HP:0003080) | 1.91571186 |
130 | Nephritis (HP:0000123) | 1.90095730 |
131 | Rapidly progressive (HP:0003678) | 1.89947695 |
132 | Lower limb amyotrophy (HP:0007210) | 1.89933421 |
133 | Amblyopia (HP:0000646) | 1.89726354 |
134 | White forelock (HP:0002211) | 1.89508154 |
135 | Stridor (HP:0010307) | 1.89141468 |
136 | Abnormality of the acetabulum (HP:0003170) | 1.88564115 |
137 | Muscle stiffness (HP:0003552) | 1.88238345 |
138 | Urinary glycosaminoglycan excretion (HP:0003541) | 1.87801790 |
139 | Mucopolysacchariduria (HP:0008155) | 1.87801790 |
140 | Obstructive sleep apnea (HP:0002870) | 1.87782687 |
141 | Striae distensae (HP:0001065) | 1.87106020 |
142 | Hypoplasia of the iris (HP:0007676) | 1.86984570 |
143 | Axonal loss (HP:0003447) | 1.86648317 |
144 | Hemiplegia (HP:0002301) | 1.86608204 |
145 | Dilated cardiomyopathy (HP:0001644) | 1.86435884 |
146 | Broad-based gait (HP:0002136) | 1.85686775 |
147 | Foot dorsiflexor weakness (HP:0009027) | 1.85498096 |
148 | Narrow nasal bridge (HP:0000446) | 1.84767377 |
149 | Abnormal delivery (HP:0001787) | 1.83861832 |
150 | Ankle contracture (HP:0006466) | 1.83319534 |
151 | Difficulty climbing stairs (HP:0003551) | 1.83131611 |
152 | Dysmetria (HP:0001310) | 1.82636801 |
153 | Neoplasm of the peripheral nervous system (HP:0100007) | 1.82573645 |
154 | Lymphangioma (HP:0100764) | 1.81478513 |
155 | Spondylolisthesis (HP:0003302) | 1.81239098 |
156 | Polycythemia (HP:0001901) | 1.81205446 |
157 | Distal lower limb amyotrophy (HP:0008944) | 1.80051334 |
158 | Venous abnormality (HP:0002624) | 1.79963379 |
159 | Cerebral inclusion bodies (HP:0100314) | 1.79958310 |
160 | Bronchomalacia (HP:0002780) | 1.79552228 |
161 | Abnormality of polysaccharide metabolism (HP:0011012) | 1.78825777 |
162 | Abnormality of glycosaminoglycan metabolism (HP:0004371) | 1.78825777 |
163 | Abnormality of mucopolysaccharide metabolism (HP:0011020) | 1.78825777 |
164 | Generalized amyotrophy (HP:0003700) | 1.78765643 |
165 | Ovoid vertebral bodies (HP:0003300) | 1.78699958 |
166 | Abnormality of the foot musculature (HP:0001436) | 1.78331569 |
167 | Hypertriglyceridemia (HP:0002155) | 1.78223492 |
168 | Spinal rigidity (HP:0003306) | 1.78091492 |
169 | Ectopia lentis (HP:0001083) | 1.77990381 |
170 | Bowel diverticulosis (HP:0005222) | 1.77822541 |
171 | Gaze-evoked nystagmus (HP:0000640) | 1.77181348 |
172 | Scotoma (HP:0000575) | 1.76602243 |
173 | Hypothermia (HP:0002045) | 1.76064961 |
174 | Oligomenorrhea (HP:0000876) | 1.74756127 |
175 | Emphysema (HP:0002097) | 1.74581207 |
176 | Ulnar deviation of the wrist (HP:0003049) | 1.73480032 |
177 | Abnormality of the lower motor neuron (HP:0002366) | 1.72641388 |
178 | Aortic regurgitation (HP:0001659) | 1.72598641 |
179 | Abnormal mitochondria in muscle tissue (HP:0008316) | 1.72192181 |
180 | Annular pancreas (HP:0001734) | 1.72070711 |
181 | Flared iliac wings (HP:0002869) | 1.72048334 |
182 | Myocardial infarction (HP:0001658) | 1.71321006 |
183 | Vascular calcification (HP:0004934) | 1.70921155 |
184 | Joint hemorrhage (HP:0005261) | 1.70580119 |
185 | Osteolytic defects of the hand bones (HP:0009699) | 1.69517923 |
Rank | Gene Set | Z-score |
---|---|---|
1 | NTRK3 | 3.67900902 |
2 | ERN1 | 3.33819383 |
3 | MAP3K4 | 2.92704647 |
4 | TGFBR2 | 2.79836128 |
5 | LMTK2 | 2.71971508 |
6 | TESK1 | 2.51300735 |
7 | PHKG2 | 2.49278394 |
8 | PHKG1 | 2.49278394 |
9 | EPHA4 | 2.45006500 |
10 | TTN | 2.39224060 |
11 | MYLK | 2.36638885 |
12 | MAP3K9 | 2.26931481 |
13 | FGFR4 | 2.18310596 |
14 | MINK1 | 2.06714957 |
15 | MAP2K7 | 1.99735523 |
16 | PINK1 | 1.92672120 |
17 | PAK6 | 1.86854342 |
18 | MAP2K4 | 1.81433088 |
19 | NTRK1 | 1.78306664 |
20 | SIK1 | 1.75527045 |
21 | PTK2 | 1.67287615 |
22 | MARK1 | 1.65136670 |
23 | MAP3K12 | 1.59259598 |
24 | DAPK2 | 1.55888256 |
25 | GRK5 | 1.55062920 |
26 | KSR2 | 1.53352017 |
27 | STK38 | 1.50827846 |
28 | MAP3K6 | 1.43054226 |
29 | EPHB1 | 1.42838291 |
30 | DMPK | 1.42603060 |
31 | PRKD3 | 1.41695762 |
32 | NTRK2 | 1.41575813 |
33 | LIMK1 | 1.40239493 |
34 | PAK3 | 1.37728873 |
35 | KIT | 1.37648186 |
36 | ICK | 1.36939088 |
37 | LATS2 | 1.35362845 |
38 | PDK3 | 1.32048566 |
39 | PDK4 | 1.32048566 |
40 | CAMKK1 | 1.29659988 |
41 | ABL2 | 1.26395600 |
42 | PRKG2 | 1.26160689 |
43 | PDGFRA | 1.25126696 |
44 | MET | 1.17546218 |
45 | PAK2 | 1.17346331 |
46 | PAK4 | 1.15768904 |
47 | PRKCH | 1.15119282 |
48 | TRIB3 | 1.14818512 |
49 | CAMK2A | 1.13332164 |
50 | WNK1 | 1.11513278 |
51 | CDK5 | 1.09137767 |
52 | GRK7 | 1.09094681 |
53 | PDGFRB | 1.06566204 |
54 | FER | 1.04880008 |
55 | PNCK | 1.04600306 |
56 | MAP3K3 | 1.03687476 |
57 | PRKD2 | 1.02518655 |
58 | RIPK1 | 1.01117724 |
59 | MUSK | 1.00997798 |
60 | ARAF | 0.99114903 |
61 | CAMK1 | 0.98086415 |
62 | PTK2B | 0.97911971 |
63 | UHMK1 | 0.95297525 |
64 | DDR2 | 0.93834729 |
65 | CAMK2D | 0.93703085 |
66 | CDC42BPA | 0.93496757 |
67 | EPHA3 | 0.92257194 |
68 | OBSCN | 0.92093716 |
69 | FLT3 | 0.91554885 |
70 | MAPK7 | 0.91271006 |
71 | PLK2 | 0.91101745 |
72 | NEK1 | 0.90657327 |
73 | CAMK1G | 0.89826871 |
74 | TIE1 | 0.89701401 |
75 | PRKCG | 0.89232125 |
76 | DYRK1B | 0.86003517 |
77 | MAPKAPK3 | 0.85699227 |
78 | MAP3K11 | 0.85388095 |
79 | PIM2 | 0.85110586 |
80 | TAOK1 | 0.84736055 |
81 | SGK223 | 0.83921971 |
82 | SGK494 | 0.83921971 |
83 | WNK4 | 0.81455192 |
84 | PRKCE | 0.80497251 |
85 | MAPK13 | 0.80320697 |
86 | CAMK2G | 0.80154313 |
87 | FGFR3 | 0.79961545 |
88 | MAP3K7 | 0.79808451 |
89 | RET | 0.77797256 |
90 | MST1R | 0.77444901 |
91 | PRPF4B | 0.77027776 |
92 | PRKAA2 | 0.76958414 |
93 | ROCK1 | 0.76808220 |
94 | EPHA2 | 0.75567175 |
95 | MAPK4 | 0.75114336 |
96 | MOS | 0.74893840 |
97 | ZAP70 | 0.74831984 |
98 | CAMKK2 | 0.74713776 |
99 | PRKD1 | 0.74228835 |
100 | PTK6 | 0.74121710 |
101 | NEK9 | 0.74065176 |
102 | PIK3CA | 0.73488081 |
103 | TBK1 | 0.73459580 |
104 | SGK3 | 0.72883370 |
105 | CAMK4 | 0.72427250 |
106 | TRPM7 | 0.71137503 |
107 | PDK2 | 0.71119250 |
108 | KSR1 | 0.69800379 |
109 | STK11 | 0.69670558 |
110 | SGK2 | 0.69347912 |
111 | FES | 0.68047534 |
112 | MAP2K1 | 0.67991181 |
113 | EEF2K | 0.67568315 |
114 | MAP3K2 | 0.67099405 |
115 | CASK | 0.65536977 |
116 | DAPK3 | 0.64575662 |
117 | ROCK2 | 0.64208053 |
118 | NME1 | 0.63543322 |
119 | TNK2 | 0.63196681 |
120 | JAK1 | 0.61723621 |
121 | SIK2 | 0.61183364 |
122 | MAP3K1 | 0.61079920 |
123 | INSRR | 0.60757770 |
124 | SMG1 | 0.60261646 |
125 | GSK3A | 0.58256003 |
126 | TYRO3 | 0.56531074 |
127 | CAMK2B | 0.55756649 |
128 | GRK6 | 0.54687637 |
129 | PKN1 | 0.54580365 |
130 | PIK3CG | 0.53570979 |
131 | PDPK1 | 0.53426387 |
132 | MAP3K13 | 0.52746970 |
133 | DAPK1 | 0.52402632 |
134 | STK39 | 0.52090419 |
135 | EPHB2 | 0.51530375 |
136 | SGK1 | 0.50970457 |
137 | MAPK12 | 0.50691375 |
138 | ADRBK1 | 0.49917587 |
139 | RPS6KA2 | 0.49616379 |
140 | MTOR | 0.49530928 |
141 | ILK | 0.48873787 |
142 | PRKACA | 0.48603331 |
143 | PKN2 | 0.48452218 |
144 | RPS6KC1 | 0.47576955 |
145 | RPS6KL1 | 0.47576955 |
146 | SRC | 0.46403877 |
147 | MARK2 | 0.46310098 |
148 | BCKDK | 0.46199409 |
149 | TAOK2 | 0.45598344 |
150 | MAP2K2 | 0.42019624 |
151 | MAP2K3 | 0.40875579 |
152 | MAP2K6 | 0.39996760 |
153 | LATS1 | 0.39041009 |
Rank | Gene Set | Z-score |
---|---|---|
1 | Synaptic vesicle cycle_Homo sapiens_hsa04721 | 2.53423629 |
2 | Nicotine addiction_Homo sapiens_hsa05033 | 2.48778527 |
3 | Complement and coagulation cascades_Homo sapiens_hsa04610 | 2.43909231 |
4 | Cyanoamino acid metabolism_Homo sapiens_hsa00460 | 2.32641829 |
5 | Cardiac muscle contraction_Homo sapiens_hsa04260 | 2.22375125 |
6 | GABAergic synapse_Homo sapiens_hsa04727 | 2.15397111 |
7 | Citrate cycle (TCA cycle)_Homo sapiens_hsa00020 | 2.12219841 |
8 | Circadian entrainment_Homo sapiens_hsa04713 | 2.08110757 |
9 | Olfactory transduction_Homo sapiens_hsa04740 | 1.99265264 |
10 | Dilated cardiomyopathy_Homo sapiens_hsa05414 | 1.97374036 |
11 | Retrograde endocannabinoid signaling_Homo sapiens_hsa04723 | 1.96943096 |
12 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 1.95225082 |
13 | Fat digestion and absorption_Homo sapiens_hsa04975 | 1.88221347 |
14 | Morphine addiction_Homo sapiens_hsa05032 | 1.86142872 |
15 | Amphetamine addiction_Homo sapiens_hsa05031 | 1.81797523 |
16 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 1.76460539 |
17 | Adrenergic signaling in cardiomyocytes_Homo sapiens_hsa04261 | 1.74726300 |
18 | Other glycan degradation_Homo sapiens_hsa00511 | 1.73365134 |
19 | Endocrine and other factor-regulated calcium reabsorption_Homo sapiens_hsa04961 | 1.73222781 |
20 | Histidine metabolism_Homo sapiens_hsa00340 | 1.70485043 |
21 | Glutamatergic synapse_Homo sapiens_hsa04724 | 1.69238198 |
22 | Salivary secretion_Homo sapiens_hsa04970 | 1.61716084 |
23 | Renin secretion_Homo sapiens_hsa04924 | 1.61670441 |
24 | Dopaminergic synapse_Homo sapiens_hsa04728 | 1.61333264 |
25 | Hypertrophic cardiomyopathy (HCM)_Homo sapiens_hsa05410 | 1.59494428 |
26 | Long-term potentiation_Homo sapiens_hsa04720 | 1.58925011 |
27 | Insulin secretion_Homo sapiens_hsa04911 | 1.57116847 |
28 | Cholinergic synapse_Homo sapiens_hsa04725 | 1.56977437 |
29 | Gastric acid secretion_Homo sapiens_hsa04971 | 1.55532257 |
30 | Aldosterone synthesis and secretion_Homo sapiens_hsa04925 | 1.55301091 |
31 | Cocaine addiction_Homo sapiens_hsa05030 | 1.53248953 |
32 | Taste transduction_Homo sapiens_hsa04742 | 1.51193141 |
33 | 2-Oxocarboxylic acid metabolism_Homo sapiens_hsa01210 | 1.49836576 |
34 | Vasopressin-regulated water reabsorption_Homo sapiens_hsa04962 | 1.49458821 |
35 | Oxidative phosphorylation_Homo sapiens_hsa00190 | 1.48291648 |
36 | Parkinsons disease_Homo sapiens_hsa05012 | 1.44608679 |
37 | Calcium signaling pathway_Homo sapiens_hsa04020 | 1.43856147 |
38 | Oxytocin signaling pathway_Homo sapiens_hsa04921 | 1.38517564 |
39 | Serotonergic synapse_Homo sapiens_hsa04726 | 1.36299941 |
40 | Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate_Homo sapiens_hsa00532 | 1.34320095 |
41 | Arrhythmogenic right ventricular cardiomyopathy (ARVC)_Homo sapiens_hsa05412 | 1.26694014 |
42 | Alzheimers disease_Homo sapiens_hsa05010 | 1.22880030 |
43 | Proximal tubule bicarbonate reclamation_Homo sapiens_hsa04964 | 1.18455576 |
44 | Collecting duct acid secretion_Homo sapiens_hsa04966 | 1.18432884 |
45 | cAMP signaling pathway_Homo sapiens_hsa04024 | 1.16087082 |
46 | GnRH signaling pathway_Homo sapiens_hsa04912 | 1.15746124 |
47 | cGMP-PKG signaling pathway_Homo sapiens_hsa04022 | 1.11817165 |
48 | Gap junction_Homo sapiens_hsa04540 | 1.10494604 |
49 | Renin-angiotensin system_Homo sapiens_hsa04614 | 1.10068823 |
50 | Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | 1.09984976 |
51 | Long-term depression_Homo sapiens_hsa04730 | 1.09175154 |
52 | Vascular smooth muscle contraction_Homo sapiens_hsa04270 | 1.07649570 |
53 | Glycerolipid metabolism_Homo sapiens_hsa00561 | 1.07245288 |
54 | Type II diabetes mellitus_Homo sapiens_hsa04930 | 1.06187117 |
55 | Fructose and mannose metabolism_Homo sapiens_hsa00051 | 1.02106943 |
56 | AGE-RAGE signaling pathway in diabetic complications_Homo sapiens_hsa04933 | 1.01777508 |
57 | Propanoate metabolism_Homo sapiens_hsa00640 | 0.99764707 |
58 | Arginine and proline metabolism_Homo sapiens_hsa00330 | 0.98782935 |
59 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 0.98225637 |
60 | Aldosterone-regulated sodium reabsorption_Homo sapiens_hsa04960 | 0.97992645 |
61 | Biosynthesis of unsaturated fatty acids_Homo sapiens_hsa01040 | 0.93284112 |
62 | Inflammatory mediator regulation of TRP channels_Homo sapiens_hsa04750 | 0.93090380 |
63 | Pertussis_Homo sapiens_hsa05133 | 0.91414479 |
64 | Sulfur metabolism_Homo sapiens_hsa00920 | 0.90763326 |
65 | Butanoate metabolism_Homo sapiens_hsa00650 | 0.90702845 |
66 | Glycosaminoglycan biosynthesis - heparan sulfate / heparin_Homo sapiens_hsa00534 | 0.90371688 |
67 | Galactose metabolism_Homo sapiens_hsa00052 | 0.90286325 |
68 | Estrogen signaling pathway_Homo sapiens_hsa04915 | 0.90197231 |
69 | Lysosome_Homo sapiens_hsa04142 | 0.89385213 |
70 | Mineral absorption_Homo sapiens_hsa04978 | 0.89063822 |
71 | Nitrogen metabolism_Homo sapiens_hsa00910 | 0.85846930 |
72 | Phototransduction_Homo sapiens_hsa04744 | 0.85113623 |
73 | AMPK signaling pathway_Homo sapiens_hsa04152 | 0.83120274 |
74 | Metabolism of xenobiotics by cytochrome P450_Homo sapiens_hsa00980 | 0.82440425 |
75 | Vitamin digestion and absorption_Homo sapiens_hsa04977 | 0.81058654 |
76 | Taurine and hypotaurine metabolism_Homo sapiens_hsa00430 | 0.80943710 |
77 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 0.80184022 |
78 | Proteoglycans in cancer_Homo sapiens_hsa05205 | 0.79849103 |
79 | Drug metabolism - cytochrome P450_Homo sapiens_hsa00982 | 0.77450512 |
80 | Vibrio cholerae infection_Homo sapiens_hsa05110 | 0.76061873 |
81 | Phenylalanine metabolism_Homo sapiens_hsa00360 | 0.75818955 |
82 | Dorso-ventral axis formation_Homo sapiens_hsa04320 | 0.75662045 |
83 | Glucagon signaling pathway_Homo sapiens_hsa04922 | 0.73942155 |
84 | Alanine, aspartate and glutamate metabolism_Homo sapiens_hsa00250 | 0.73791854 |
85 | Neuroactive ligand-receptor interaction_Homo sapiens_hsa04080 | 0.73183554 |
86 | Huntingtons disease_Homo sapiens_hsa05016 | 0.71363716 |
87 | Melanogenesis_Homo sapiens_hsa04916 | 0.70601468 |
88 | Chemical carcinogenesis_Homo sapiens_hsa05204 | 0.69920836 |
89 | Non-alcoholic fatty liver disease (NAFLD)_Homo sapiens_hsa04932 | 0.69703293 |
90 | Axon guidance_Homo sapiens_hsa04360 | 0.69436399 |
91 | Arginine biosynthesis_Homo sapiens_hsa00220 | 0.68880742 |
92 | Pyruvate metabolism_Homo sapiens_hsa00620 | 0.68013303 |
93 | Fatty acid metabolism_Homo sapiens_hsa01212 | 0.65230818 |
94 | Bile secretion_Homo sapiens_hsa04976 | 0.64498255 |
95 | Bacterial invasion of epithelial cells_Homo sapiens_hsa05100 | 0.63993391 |
96 | Starch and sucrose metabolism_Homo sapiens_hsa00500 | 0.63729649 |
97 | Phospholipase D signaling pathway_Homo sapiens_hsa04072 | 0.63632214 |
98 | Pancreatic secretion_Homo sapiens_hsa04972 | 0.63392225 |
99 | ECM-receptor interaction_Homo sapiens_hsa04512 | 0.63233485 |
100 | Glioma_Homo sapiens_hsa05214 | 0.62752796 |
101 | Phosphatidylinositol signaling system_Homo sapiens_hsa04070 | 0.62498257 |
102 | Regulation of actin cytoskeleton_Homo sapiens_hsa04810 | 0.62400185 |
103 | Thyroid hormone synthesis_Homo sapiens_hsa04918 | 0.62304376 |
104 | PI3K-Akt signaling pathway_Homo sapiens_hsa04151 | 0.62206268 |
105 | Insulin signaling pathway_Homo sapiens_hsa04910 | 0.61907887 |
106 | Tryptophan metabolism_Homo sapiens_hsa00380 | 0.61766627 |
107 | Sulfur relay system_Homo sapiens_hsa04122 | 0.61590424 |
108 | Ovarian steroidogenesis_Homo sapiens_hsa04913 | 0.60810855 |
109 | Malaria_Homo sapiens_hsa05144 | 0.59758705 |
110 | Glycolysis / Gluconeogenesis_Homo sapiens_hsa00010 | 0.57727453 |
111 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.56972700 |
112 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 0.55152830 |
113 | Retinol metabolism_Homo sapiens_hsa00830 | 0.54938350 |
114 | Fatty acid degradation_Homo sapiens_hsa00071 | 0.54115434 |
115 | Amino sugar and nucleotide sugar metabolism_Homo sapiens_hsa00520 | 0.53400350 |
116 | Focal adhesion_Homo sapiens_hsa04510 | 0.53178484 |
117 | Carbon metabolism_Homo sapiens_hsa01200 | 0.52517386 |
118 | MAPK signaling pathway_Homo sapiens_hsa04010 | 0.51718114 |
119 | ErbB signaling pathway_Homo sapiens_hsa04012 | 0.50597018 |
120 | Protein digestion and absorption_Homo sapiens_hsa04974 | 0.50087893 |
121 | PPAR signaling pathway_Homo sapiens_hsa03320 | 0.49876505 |
122 | Fatty acid biosynthesis_Homo sapiens_hsa00061 | 0.49048935 |
123 | Longevity regulating pathway - multiple species_Homo sapiens_hsa04213 | 0.48745838 |
124 | Synthesis and degradation of ketone bodies_Homo sapiens_hsa00072 | 0.46676636 |
125 | ABC transporters_Homo sapiens_hsa02010 | 0.46401656 |
126 | Notch signaling pathway_Homo sapiens_hsa04330 | 0.46307351 |
127 | Small cell lung cancer_Homo sapiens_hsa05222 | 0.46161517 |
128 | Central carbon metabolism in cancer_Homo sapiens_hsa05230 | 0.46081918 |
129 | Leukocyte transendothelial migration_Homo sapiens_hsa04670 | 0.45292159 |
130 | Prion diseases_Homo sapiens_hsa05020 | 0.45151762 |
131 | Tyrosine metabolism_Homo sapiens_hsa00350 | 0.44878654 |
132 | Thyroid hormone signaling pathway_Homo sapiens_hsa04919 | 0.44261024 |
133 | Longevity regulating pathway - mammal_Homo sapiens_hsa04211 | 0.44082378 |
134 | beta-Alanine metabolism_Homo sapiens_hsa00410 | 0.43744869 |
135 | Glutathione metabolism_Homo sapiens_hsa00480 | 0.43681335 |
136 | Epithelial cell signaling in Helicobacter pylori infection_Homo sapiens_hsa05120 | 0.42981465 |
137 | Amoebiasis_Homo sapiens_hsa05146 | 0.42832232 |
138 | Arachidonic acid metabolism_Homo sapiens_hsa00590 | 0.42689404 |
139 | Circadian rhythm_Homo sapiens_hsa04710 | 0.42564940 |
140 | Ras signaling pathway_Homo sapiens_hsa04014 | 0.41781778 |
141 | Endocytosis_Homo sapiens_hsa04144 | 0.41603502 |
142 | Insulin resistance_Homo sapiens_hsa04931 | 0.41241736 |
143 | Glycerophospholipid metabolism_Homo sapiens_hsa00564 | 0.40290077 |
144 | Tight junction_Homo sapiens_hsa04530 | 0.40279189 |
145 | Choline metabolism in cancer_Homo sapiens_hsa05231 | 0.38414535 |
146 | Rap1 signaling pathway_Homo sapiens_hsa04015 | 0.38309985 |
147 | Glycosaminoglycan biosynthesis - keratan sulfate_Homo sapiens_hsa00533 | 0.34884303 |